CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 50 enrolled
Drug / intervention
LipiFlow Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01202747
NCT01202747Phase 3Completed
CompareCT.gov

Pilot Study for Evaluation of LipiFlow Screening Methods

TearScience, Inc.·interventional·Posted Sep 16, 2010·Updated Dec 6, 2011

In Brief

A Phase 3 clinical trial evaluating LipiFlow System for Chalazion and Dry Eye Syndromes. Completed, enrolled 50 participants across 3 sites.

Detailed Summary

The objective is to evaluate the feasibility of using additional screening methods to optimize effectiveness outcomes with the LipiFlow System for application of heat and pressure therapy in adult patients with chronic cystic conditions of the eyelids, including meibomian gland dysfunction, also known as evaporative dry eye or lipid deficiency dry eye, and chalazia. The screening methods include diagnostic expression of the meibomian glands and interferometry assessment of the tear film.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChalazion, Dry Eye Syndromes
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedSep 16, 2010
Enrollment StartSep 1, 2010
Primary CompletionJan 1, 2011
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 15.8 years ago

Interventions

LipiFlow Systemdevice

In-office treatment for meibomian gland dysfunction